Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In Vivo Metabolism of apoB-containing Lipoproteins in ANGPTL3 Deficient Subjects

NCT05569928 is registered in ClinicalTrials.gov with Marcello Arca as lead sponsor.

NCT NCT05569928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05569928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In Vivo Metabolism of apoB-containing Lipoproteins in ANGPTL3 Deficient Subjects
Lead sponsor
Marcello Arca
Phase
Not applicable
Overall status
Unknown status
Start date
September 30, 2022
Completion date
January 30, 2025
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

familial hypobetalipoproteinemia, familial hypobetalipoproteinemia - heterozygous form